Identification of germline missense mutations and rare allelic variants in the ATM gene in early‐onset breast cancer
暂无分享,去创建一个
C. Mathew | M. Zvelebil | S. Hodgson | L. Izatt | D. Ellis | E. Solomon | S. Watts | C. Jacobs | Gillian Scott | Jill Greenman | Rachael Liebmann
[1] S. Hodgson,et al. Rapid and efficient ATM mutation detection by fluorescent chemical cleavage of mismatch: identification of four novel mutations , 1999, European Journal of Human Genetics.
[2] S. Seal,et al. Heterozygosity for mutations in the ataxia telangiectasia gene is not a major cause of radiotherapy complications in breast cancer patients. , 1998, British Journal of Cancer.
[3] M. Lavin,et al. Testing for mutations of the ataxia telangiectasia gene in radiosensitive breast cancer patients. , 1998, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[4] A. Lindblom,et al. The role of ataxia-telangiectasia heterozygotes in familial breast cancer. , 1998, Cancer research.
[5] C. Mathew,et al. Identification of missense and truncating mutations in the BRCA1 gene in sporadic and familial breast and ovarian cancer , 1998, Genes, chromosomes & cancer.
[6] D. Easton,et al. ATM mutations and phenotypes in ataxia-telangiectasia families in the British Isles: expression of mutant ATM and the risk of leukemia, lymphoma, and breast cancer. , 1998, American journal of human genetics.
[7] M. Dyer,et al. Clustering of missense mutations in the ataxia-telanglectasia gene in a sporadic T-cell leukaemia , 1997, Nature Genetics.
[8] Y. Shiloh,et al. Ataxia-telangiectasia locus: sequence analysis of 184 kb of human genomic DNA containing the entire ATM gene. , 1997, Genome research.
[9] A. Børresen-Dale,et al. Loss of heterozygosity at 11q23.1 in breast carcinomas: Indication for involvement of a gene distal and close to ATM , 1997, Genes, chromosomes & cancer.
[10] K. Isselbacher,et al. Heterozygous ATM mutations do not contribute to early onset of breast cancer , 1997, Nature Genetics.
[11] M. Swift,et al. Molecular genotyping shows that ataxia-telangiectasia heterozygotes are predisposed to breast cancer. , 1996, Cancer genetics and cytogenetics.
[12] I. Ellis,et al. High levels of allele loss at the FHIT and ATM genes in non-comedo ductal carcinoma in situ and grade I tubular invasive breast cancers. , 1996, Cancer research.
[13] C. Croce,et al. ATM mutations in cancer families. , 1996, Cancer research.
[14] F. Collins,et al. Identification and chromosomal localization of Atm, the mouse homolog of the ataxia-telangiectasia gene. , 1996, Genomics.
[15] M. James,et al. The ATM gene and susceptibility to breast cancer: analysis of 38 breast tumors reveals no evidence for mutation. , 1996, Cancer research.
[16] F. Collins,et al. The complete sequence of the coding region of the ATM gene reveals similarity to cell cycle regulators in different species. , 1995, Human molecular genetics.
[17] D. Eccles,et al. Chromosome 11 allele imbalance and clinicopathological correlates in ovarian tumours. , 1995, British Journal of Cancer.
[18] G. Hampton,et al. Definition and refinement of chromosome 11 regions of loss of heterozygosity in breast cancer: identification of a new region at 11q23.3. , 1995, Cancer research.
[19] M. Lovett,et al. A single ataxia telangiectasia gene with a product similar to PI-3 kinase. , 1995, Science.
[20] G. Hampton,et al. A defined region of loss of heterozygosity at 11q23 in cutaneous malignant melanoma. , 1995, Cancer research.
[21] J. Thompson,et al. CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. , 1994, Nucleic acids research.
[22] G. Chenevix-Trench,et al. Loss of heterozygosity on the long arm of chromosome 11 in colorectal tumours. , 1994, British Journal of Cancer.
[23] G. Hampton,et al. Loss of heterozygosity in cervical carcinoma: subchromosomal localization of a putative tumor-suppressor gene to chromosome 11q22-q24. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[24] G. Taylor,et al. Rapid detection of allele loss in colorectal tumours using microsatellites and fluorescent DNA technology. , 1993, British Journal of Cancer.
[25] D Morrell,et al. Incidence of cancer in 161 families affected by ataxia-telangiectasia. , 1991, The New England journal of medicine.
[26] M. Baudis,et al. Modification of enzymatically amplified DNA for the detection of point mutations. , 1989, Nucleic acids research.
[27] A. Hall,et al. Cancer in homozygotes and heterozygotes of ataxia-telangiectasia and xeroderma pigmentosum in Britain. , 1988, Cancer research.
[28] Shirley A. Miller,et al. A simple salting out procedure for extracting DNA from human nucleated cells. , 1988, Nucleic acids research.
[29] P. Chomczyński,et al. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. , 1987, Analytical biochemistry.
[30] P. Parsons,et al. Radiosensitive melanoma cell line with mutation of the gene for ataxia telangiectasia. , 1998, British Journal of Cancer.
[31] T. Stankovic,et al. Absence of mutations in the ATM gene in breast cancer patients with severe responses to radiotherapy. , 1997, British Journal of Cancer.
[32] Y. Shiloh,et al. The genetic defect in ataxia-telangiectasia. , 1997, Annual review of immunology.
[33] R. Cowan,et al. A comparison of the radiosensitivity of lymphocytes from normal donors, cancer patients, individuals with ataxia-telangiectasia (A-T) and A-T heterozygotes. , 1995, International journal of radiation biology.
[34] R. Cowan,et al. Abnormal radiosensitivity of lymphocytes from breast cancer patients with excessive normal tissue damage after radiotherapy: chromosome aberrations after low dose-rate irradiation. , 1995, International journal of radiation biology.
[35] D. Easton. Cancer Risks in A-T Heterozygotes. , 1994, International journal of radiation biology.